BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 22542126)

  • 21. Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).
    Jones TD; Cheng L
    Histopathology; 2020 Oct; 77(4):525-535. PubMed ID: 32562556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
    Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
    BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 2004 WHO classification of bladder tumors: a summary and commentary.
    Montironi R; Lopez-Beltran A
    Int J Surg Pathol; 2005 Apr; 13(2):143-53. PubMed ID: 15864376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.
    Holmäng S; Johansson SL
    Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New WHO classification of urothelial carcinoma of the urinary bladder].
    Helpap B
    Verh Dtsch Ges Pathol; 2002; 86():57-66. PubMed ID: 12647352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.
    Maxwell JP; Wang C; Wiebe N; Yilmaz A; Trpkov K
    Diagn Pathol; 2015 Mar; 10():3. PubMed ID: 25886613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].
    Helpap B; Köllermann J
    Pathologe; 2000 May; 21(3):211-7. PubMed ID: 10900613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.
    Toll AD; Epstein JI
    Am J Surg Pathol; 2012 Jul; 36(7):1081-6. PubMed ID: 22510761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center.
    Lee TK; Chaux A; Karram S; Miyamoto H; Miller JS; Fajardo DA; Epstein JI; Netto GJ
    Hum Pathol; 2011 Nov; 42(11):1799-803. PubMed ID: 21777949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.
    Cao D; Vollmer RT; Luly J; Jain S; Roytman TM; Ferris CW; Hudson MA
    Urology; 2010 Sep; 76(3):593-9. PubMed ID: 20381131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?
    Burger M; Denzinger S; Wieland WF; Stief CG; Hartmann A; Zaak D
    BJU Int; 2008 Jul; 102(2):194-7. PubMed ID: 18435811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urothelial papilloma of the bladder. Clinical and biologic implications.
    Cheng L; Darson M; Cheville JC; Neumann RM; Zincke H; Nehra A; Bostwick DG
    Cancer; 1999 Nov; 86(10):2098-101. PubMed ID: 10570437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.